Paid Clinical Trials in Lansing, MI
As of September 2026, 130 paid clinical trials are recruiting in Lansing, Michigan. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Lansing offers studies at sites including University of Michigan Health - Sparrow Lansing for conditions such as Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer, Stage IVB Prostate Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Lansing
Trials by drug in Lansing
Filter results
128 clinical trials
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Patient Retrospective Outcomes (PRO)
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
C-Brace Prospective Registry
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
Study to Evaluate the REMEDY SPECTRUM GV IM Spacer Nail in the Treatment of Ankle-Related Infections
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Family Communications After Genetic Testing
Top Research Study Locations in Lansing
Researchers run research studies in Lansing, MI at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Michigan Health - Sparrow Lansing | Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma | 64 |
| Karmanos Cancer Institute at McLaren Greater Lansing | Anatomic Stage II Breast Cancer AJCC v8, AL Amyloidosis, Advanced Esophageal Adenocarcinoma | 19 |
| Alkermes Investigational Site | Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia | 4 |
| Sparrow Clinical Research Institute | Aortic Stenosis, Coronary Artery Disease, Coronary Stenosis | 4 |
| Clinical Trial Site | Generalized Myasthenia Gravis, High Cardiovascular Risk, High Risk Cardiovascular Disease | 2 |
| Michigan State University | Acute Ischemic Stroke, Cancer Prevention, HPV Vaccination | 2 |
| Sparrow Cancer Center | Breast Cancer, Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion | 2 |
| Sparrow Hospital | Anatomic Stage IV Breast Cancer AJCC v8, Castration Levels of Testosterone, Elevated CA15-3 or CEA or CA27-29 | 2 |
| Advanced Rheumatology PC | Lansing, MI | Psoriatic Arthritis | 1 |
| Alkermes Investigator Site | Idiopathic Hypersomnia | 1 |
| Anthos Investigational | Atrial Fibrillation (AF) | 1 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| Barbara Ann Karmanos Cancer Institute | Metastatic Castration-resistant Prostate Cancer | 1 |
| E.W Sparrow Hospital | Stone Ureter, Stone, Kidney | 1 |
| Genesis Surgery Center | Lumbar Spinal Stenosis | 1 |
| Great Lakes Center of Rheumatology | Active Rheumatoid Arthritis | 1 |
| Henry Ford + Michigan State University Health Center | Alcohol Use Disorder, Alcohol-related Liver Disease | 1 |
| Herbert-Herman Cancer Center, Sparrow Hospital | Angiosarcoma, Breast Cancer, Breast Neoplasms | 1 |
| Home-based telemedicine | Chronic Granulomatous Disease (CGD) | 1 |
| Ingham Nephrology & Hypertension, P.C. | Kidney Disease | 1 |
| June DO PC | Uncontrolled Gout | 1 |
| June DO, PC | Systemic Lupus Erythematosus | 1 |
| June DO, PC Private Practice - Dr. Justus Fiechtner | Psoriatic Arthritis | 1 |
| KCI at McLaren Greater Lansing | Multiple Myeloma | 1 |
| MSU Center for Bleeding and Clotting Disorders | Hemophilia A With Inhibitor, Hemophilia B With Inhibitor | 1 |
Active & Upcoming Studies in Lansing (2026)
Recruiting trials in Lansing grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (76 active studies)
- A Study of the TheraBionic P1 Device in Breast Cancer · Barbara Ann Karmanos Cancer Institute
- Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial · Phase 3 · National Cancer Institute (NCI)
Cardiovascular (13 active studies)
- Ask Questions About Clinical Trials · Barbara Ann Karmanos Cancer Institute
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Neurology & pain (3 active studies)
- Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures · Phase 4 · University of Michigan
- Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial · Phase 3 · Mercy Health Ohio
Diabetes & metabolic (2 active studies)
Vaccines (1 active study)
Mental health & behavior (1 active study)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
Common conditions studied in Lansing
- Stage IV Lung Cancer AJCC v8 (6 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (5 active studies)
- Breast Cancer (5 active studies)
- Stage IVB Prostate Cancer AJCC v8 (5 active studies)
- Recurrent Lung Non-Small Cell Carcinoma (4 active studies)
- Stage IIIB Lung Cancer AJCC v8 (4 active studies)
Leading research sponsors in Lansing
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- NRG Oncology
- Barbara Ann Karmanos Cancer Institute
Frequently asked questions
How many paid clinical trials are currently recruiting in Lansing?
There are approximately 130 recruiting clinical trials in Lansing, Michigan listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Lansing pay participants?
Most recruiting trials in Lansing compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Lansing?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Lansing?
The most common conditions under active study in Lansing include Stage IV Lung Cancer AJCC v8 (6), Anatomic Stage II Breast Cancer AJCC v8 (5), Breast Cancer (5), Stage IVB Prostate Cancer AJCC v8 (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Lansing?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Lansing on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Lansing?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Lansing?
Recruiting research sites in Lansing include University of Michigan Health - Sparrow Lansing, Karmanos Cancer Institute at McLaren Greater Lansing, Alkermes Investigational Site, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Lansing right now?
The largest active categories in Lansing are Cancer & tumors (76), Cardiovascular (13), Neurology & pain (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.